Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease.
Baranyi M, Porceddu PF, Gölöncsér F, Kulcsár S, Otrokocsi L, Kittel Á, Pinna A, Frau L, Huleatt PB, Khoo ML, Chai CL, Dunkel P, Mátyus P, Morelli M, Sperlágh B.
Baranyi M, et al. Among authors: huleatt pb.
Mol Neurodegener. 2016 Jan 13;11:6. doi: 10.1186/s13024-015-0067-y.
Mol Neurodegener. 2016.
PMID: 26758813
Free PMC article.